Xerostomia in Head and Neck Malignancy

Overview

Journal Oral Oncol

Publisher Elsevier

Specialty Dentistry

Date 2010 Apr 21

PMID 20403723

Citations 13

Authors

S R Porter

S Fedele

K M Habbab

Affiliations

Soon will be listed here.

Abstract

Xerostomia (dry mouth) as a consequence of treatment of head and neck malignancy is almost always due to radiotherapy. The resultant salivary gland dysfunction can adversely affect oral and systemic health as well as lessen quality of life. While the present management of radiotherapy-associated salivary dysfunction is challenging there have been striking advances in preventative strategies and a number of possible treatment options may be over the near horizon.

Citing Articles

Will Nigella sativa oil protect parotid glands of rats against cranium gamma irradiation? Histological and immunohistochemical evaluation.

Ahmed S, Bakr M BMC Complement Med Ther. 2024; 24(1):111.

PMID: 38448931 PMC: 10916243. DOI: 10.1186/s12906-024-04410-8.

Research Value of Intensity Modulated Radiation Therapy in Alleviating Parotid Gland Function Injury in Patients with Stage N0 Nasopharyngeal Carcinoma from Physical and Dosimetric Aspects.

Zheng L, Wang H, Yang N, Du F, Xiao L, Wu G Comput Math Methods Med. 2022; 2022:4651364.

PMID: 35860184 PMC: 9293508. DOI: 10.1155/2022/4651364.

Radioprotective effects and mechanism of HL-003 on radiation-induced salivary gland damage in mice.

Ren J, Huang R, Li Y, Chen R, Tian H, Liu C Sci Rep. 2022; 12(1):8419.

PMID: 35589816 PMC: 9120142. DOI: 10.1038/s41598-022-12581-y.

Noninvasive Systemic Modalities for Prevention of Head and Neck Radiation-Associated Soft Tissue Injury: A Narrative Review.

Kim L, Rubenstein R, Chu J, Allen Jr R, Mehrara B, Nelson J J Reconstr Microsurg. 2022; 38(8):621-629.

PMID: 35213927 PMC: 9402815. DOI: 10.1055/s-0042-1742731.

The Long-Term Recovery of Parotid Glands in Nasopharyngeal Carcinoma Treated by Intensity-Modulated Radiotherapy.

Tasaka S, Jingu K, Takahashi N, Umezawa R, Yamamoto T, Ishikawa Y Front Oncol. 2021; 11:665837.

PMID: 34026643 PMC: 8138171. DOI: 10.3389/fonc.2021.665837.